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Abstract  
Background: Evidence suggests changes in the processing of emotional information (EP) in 
people with multiple sclerosis (MS). It is unclear which functional domains of EP are affected, 
whether these changes are secondary to other MS-related neuropsychological or psychiatric 
symptoms and if EP changes are present in early MS. 
Objective: To investigate EP in patients with early MS (clinically isolated syndrome and early 
relapsing/remitting MS) and healthy controls (HC).
Methods: 29 patients without neuropsychological deficits and 29 matched HC were presented 
IAPS-pictures with negative, positive or neutral content. Participants rated the induced emotion 
regarding valence and arousal using 9-level Likert scales. A speeded recognition test assessed 
memory for the emotional stimuli and for the emotional modulation of response time. A subgroup 
of participants was tested during a magnetic resonance imaging (MRI) session.
Results: Patients in the MRI-subgroup rated the experience induced by pictures with positive or 
negative emotional content significantly weaker than HCs. Further, these patients were 
significantly less aroused watching the IAPS pictures. There were neither effects in the non-MRI-
subgroup nor effects on emotional memory or response times.
Conclusion: EP changes may be present in early MS in the form of flattened emotional 
experience on both the valence and arousal dimension. These changes do not appear to be 
secondary to neuropsychological or neuropsychiatric deficits. The fact that emotional flattening 
was only found in the MRI-setting, suggests that EP changes may be unmasked within stressful 
environments and points to the potential yet underestimated impact of the MRI-setting on A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved
behavioral outcomes.
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Introduction 
Controversial evidence suggests deficits in the processing of emotional information (EP) in 
patients with MS. Reported EP deficits in MS include specific difficulties detecting particularly 
negative emotional facial expressions [1-3], comprehending affective prosody [4], recognizing 
emotional compared to neutral visual stimuli and events, or defective emotional enhancement of 
verbal memory [5].
Several studies suggest that deficits decoding facial emotions of anger and fear might be related 
to general cognitive deficits and in particular to measures sensitive to executive dysfunction and 
information processing speed [1,6,7] or to depressed mood [8]. Other studies, evaluating 
emotional prospective memory in patients with MS, were not able to find deficits [9]. 
Krause et al. [10] in an fMRI study report impaired negative emotional facial recognition 
performance in moderately advanced MS and found decreased anterior insular and ventrolateral 
PFC activation. In contrast, in patients without EP deficits on emotional recognition tasks, 
enhanced, potentially compensatory brain mechanisms in regions known to be involved in the 
processing of emotional information appear to limit the clinical manifestation of EP changes 
[11,12]. In the same vein, Migliore et al. [13] found higher P300 amplitudes in relation to 
emotional IAPS-pictures in moderately advanced MS.  
In summary, it remains unclear which functional domains of EP are affected, whether EP deficits 
in MS are specific to the emotional valence (positive, neutral, negative) and/or arousal dimension 
and if EP deficits are secondary to other MS-related neuropsychological or psychiatric symptoms. 
We ascertained the effects of emotional stimuli on subjective experience, response time and 
recognition memory performance. To limit the presence of factors potentially impacting EP we 
enrolled patients in early stages of the disease and controlled for a variety of neuropsychological 
and -psychiatric measures. 
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Participants
Twenty nine Caucasian right-handed patients with clinically isolated syndrome (CIS) (n=8) or 
relapsing remitting MS (RRMS; n=21) [14] within ≤5 years and 29 right-handed matched healthy 
controls (Table 1) were tested. The study was approved by the Charité - Universitätsmedizin 
Berlin ethics committee and registered at ClinicalTrials.gov (NCT02695394). Written informed 
consent was obtained from all participants. 32 participants (16 patients/16 HC) were tested during 
a magnetic resonance imaging (MRI) session; the remaining 26 participants (13 patients/13 HC) 
conducted the experiment in a behavioral laboratory using a PC (Table 1 and Supplementary 
material). The participants were randomized to undergo the testing with or without MRI.  
Exclusion criteria were cognitive deficits (Mini Mental State Examination (MMSE) Score < 25/30) 
[15], clinically significant diseases within 7 days prior to the study evaluations, physical disabilities 
interfering with the study procedures, depression and anxiety (Hospital Anxiety and Depression 
Scale Score, HADS-D >7 and HADS-A >7, respectively) [16].
------------------------------------------------------------
Please insert Table 1 about here.
------------------------------------------------------------
Neuropsychological background testing, health-related quality of life, satisfaction with life and 
emotional wellbeing
To test verbal learning and memory, visuospatial learning and recall, attention, sustained 
attention and speed of information processing and verbal fluency/executive functioning, the Brief 
Repeatable Battery of Neuropsychological Tests (BRB-N) [18] was used (Table 1 & Supporting 
information).  
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved
To test for fatigue, the Modified Fatigue Impact Scale (MFIS) [19] was used and to probe for 
depression, the Beck Depression Inventory (BDI-2) [20] was employed. 
Further, health-related quality of life (SF-36) [21], Satisfaction with life (Satisfaction with Life 
Scale, SWLS) [22] and emotional wellbeing (Positive and Negative Affect Schedule, PANAS) [23] 
were examined. 
Emotional processing testing
Participants were presented on a computer screen a series of 54 neutral and emotional pictures 
(e.g., accident victims, erotica, daily life objects etc.) from the International Affective Picture 
System (IAPS). Pictures differed in valence (18 positive, 18 neutral, 18 negative) and arousal (27 
low, 27 high) based on standardized published rating values. Half of the pictures of each of the 
three valence categories had high and low arousal values, respectively (Supporting information) 
[24]. Each picture was presented for 6 seconds. After each picture, participants rated the emotion 
elicited by the picture regarding its valence and arousal using 9-level Self Assessment Manikin 
Likert scales (Figure 1) [25].
After a delay of 15 minutes, there was a speeded recognition test for the stimuli previously 
presented (“old”) and for distractors (“new”), also comprising neutral and emotional pictures 
(Supporting information). Experiential rating means, %-correct recognized emotional items and 
the modulation of response time by emotional stimulus characteristics served as outcome 
variables [26,27]. 
--------------------------------------------------------------------------------------
Please insert Figure 1 about here
--------------------------------------------------------------------------------------
Statistical analysis 
Demographical and clinical variables were analyzed descriptively and differences between A
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subgroups were ascertained by Chi-Square tests or analyses of variance for between subject 
factors GROUP (Patients/HC) and EXPERIMENTAL SETTING (PC/MRI). 
Primary behavioral endpoints were analyzed descriptively and subjected to mixed-model 
repeated-measures ANCOVAs with between subject factors GROUP (Patients, HC) and 
EXPERIMENTAL SETTING (PC, MRI) and within subject factors VALENCE (negative, positive, 
neutral) and AROUSAL (high, low). To address potential paradigm unspecific effects on 
emotional processes, we used age, sex and depression severity (BDI-2) as covariates for the 
analyses of valence and arousal ratings, recognition performance and response times. The mean 
values of these primary endpoint variables were used as dependent variables in separate 
ANCOVAs. In case of sphericity violation, degrees of freedom were Greenhouse-Geisser 
corrected. Directions of main effects and interactions were post-hoc assessed via t-tests. Two-
tailed p-values were reported for all effects. The level of significance for all tests was adjusted to 
α = 5%, and if applicable corrected for multiple testing (Supporting information). 
Correlations between valence and arousal ratings (corrected for age, sex, BDI-2 and 
experimental setting) and health-related quality of life, satisfaction with life, emotional wellbeing 
and fatigue were analyzed by means of Spearman correlation analysis (Supporting information). 
Results
Demographic characteristics, neuropsychological background testing, quality of life, wellbeing 
and satisfaction with life
There were no significant group or experimental setting associated differences, except for the 
general health perception subscore of the SF-36, which indicated reduced health perception in 
patients (p = .047; Table 1). 
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--------------------------------------------------------------------------------------
Please insert Table 1 about here.
--------------------------------------------------------------------------------------
Emotional experience
Valence Rating
There was a main effect of VALENCE (Table 2, Figure 2A, Table S3). Post-hoc tests revealed 
that the valence of pictures with positive content was rated higher than the valence of neutral and 
negative pictures and that the valence of neutral pictures was rated higher than the valence of 
negative pictures. Further, there was an interaction VALENCE x GROUP. Patients rated negative 
and neutral pictures consistently less emotional than HC. Finally, there was an interaction 
VALENCE x GROUP x EXPERIMENTAL SETTING. Interestingly, post-hoc tests revealed that 
patients from the MRI-setting rated negative and positive pictures consistently less emotional, i.e. 
more neutral, than healthy controls (Figure 2A). In contrast, this effect was not found in the PC 
group.
Arousal Rating
There was a main effect of AROUSAL, indicating that the arousal of highly arousing pictures was 
rated higher than the arousal of less arousing pictures (Table 2, Figure 2B and Table S3). A main 
effect of GROUP indicated that, overall, patients were generally less aroused than healthy control 
subjects. However, as revealed by an interaction GROUP x  EXPERIMENTAL SETTING, this 
effect was found only in the MRI sample. Finally, there was an interaction AROUSAL x GROUP x 
EXPERIMENTAL SETTING. In the MRI-setting, patients experienced low and high arousing 
pictures less arousing than HCs (Table 2B). In contrast, in the PC-setting, ratings did not differ 
significantly between groups. Compatible with this, the patients in the MRI-setting rated pictures 
significantly lower regarding their arousal than patients in the PC-setting.
Recognition Memory Performance & Modulation of Response time
Our analyses revealed no interactions involving the factor GROUP (Table 2, Table S3).
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--------------------------------------------------------------------------------------
Please insert Table 2 and Figure 2 about here.
--------------------------------------------------------------------------------------
Correlation analysis
For patients, but not controls, there was a positive correlation between SWLS sum score and 
valence ratings for highly arousing, positive pictures (Table 3; Supporting information). Further, 
significant between group differences in correlations between valence ratings and the following 
three SF36 subscales were found: emotional role function, physical functioning and physical 
health (Table 3; Supporting information). 
 
--------------------------------------------------------------------------------------
Please insert Table 3 about here.
--------------------------------------------------------------------------------------
Discussion
We here provide evidence that emotional experience in patients with early MS without 
neuropsychiatric or cognitive deficits may be flattened on the full range of emotional valence and 
arousal. This effect was only found in patients tested in an MRI-setting and suggests that 
emotional flattening in early MS may manifest only in stressful environments such as in MRI-
settings. 
Previous EP research in MS focused primarily on discrete emotions (i.e., anger, happiness, etc.). 
For example, studies using emotional facial recognition or classification paradigms provide 
evidence for altered processing particularly of negative discrete emotions [1,3]. The only prior A
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study in MS patients that used a dimensional approach [28] evaluated 13 patients using merely 
four IAPS stimuli per stimulus category. Whereas patients experienced negative but not positive 
visual stimuli as less arousing than healthy controls, the experience of emotional valence was not 
found to be altered. Our behavioral data suggest that EP deficits appear to be broader than 
suggested by previous research and involve both negative and positive valence as well as the 
arousal dimension. 
Several rather heterogeneous studies suggest that emotional processing deficits might be related 
to cognitive deficits [1,2,6] or neuropsychiatric symptoms such as depression [8]. The inclusion of 
patients with CIS and early MS without cognitive deficits and mood changes aimed at limiting the 
presence of these and other confounding factors such as relevant disease related disability or 
limitations in quality of life. In fact, there were no differences between patients and healthy 
controls on demographics and neuropsychological background measures. We therefore deem 
unlikely that the flattened emotional responses observed here are secondary to cognitive or 
neuropsychiatric deficits. The result is rather compatible with the view of a primary deficit in the 
processing of emotional stimulus information in patients with MS.
The “flattening” of the experiential response to emotional stimuli in our study was not 
accompanied by effects on other EP measures such as emotional recognition memory or 
response time. We cannot exclude the possibility that the power in our study was not sufficient. 
There is evidence that the processing of emotional information relies on different neural networks 
with certain processing streams being specifically involved with higher order processing while 
others mediate the automatic processing of ecologically relevant information enabling the 
organism to fast behavioral responses that are not modulated by higher order processing [29]. It 
is conceivable yet speculative that the disease process at least early in the course of disease 
progression primarily affects structures involved in higher order EP.
Unexpectedly, EP changes were found only in the MRI-subgroup. Patients had been randomized 
to undergo the experiment in either the MRI or the PC-setting and both subgroups did not differ 
on clinical and demographic variables. We therefore hypothesize that the consistent effect of 
flattened emotional experience seen in MS patients in the MRI-subgroup originates from an 
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interaction of subclinical EP deficits and effects of the MRI environment. Few studies examined 
the effects of the MRI-setting on behavioral task performance. Evidence suggests that supine 
position, enclosed environment and noise may affect attention, mood or arousal in healthy 
individuals [30,31,32] with negative as well as positive neuropsychological effects [31,33]. 
Further, the scanner environment presumably is of different psychological significance for MS 
patients given the importance of MRI-scanning for MS-diagnosis, -prognosis and therapy 
decisions. In conclusion, we speculate that EP deficits in our patients with early MS were 
unmasked within the MRI-setting. This hypothesis will have to be confirmed and the underlying 
specific mechanisms will have to be disentangled by future research. 
Besides the overall flattened experiential responses to emotional stimuli, correlation analysis 
revealed that patients with higher life satisfaction experience high arousal positive pictures more 
positively. Further, significant between group differences in correlations between valence ratings 
and the following three SF36 subscales were found: emotional role function, physical functioning 
and physical health. We interpret these correlations as signals for a potential link of emotional 
processing capabilities and life satisfaction and health-related quality of life in MS. However, 
further hypothesis driven research is needed to substantiate this link, which to our knowledge has 
not been reported previously. 
There are limitations to the present study. Importantly, the overall sample size was relatively 
small and the finding of EP changes in early MS was observed in an even smaller subgroup of 
patients. The results of this study therefore will have to be confirmed by future research involving 
larger sample sizes. Further, the study focused on early MS. No conclusions can be drawn with 
respect to later stages of the disease. Moreover, the MMSE has severe limitations when used in 
patients with MS and there are more sensitive alternatives to the BRB-N as neuropsychological 
background evaluation. Finally, we cannot fully exclude a systematic disease specific picture bias 
with different relevance of certain picture contents for patients compared to healthy individuals.  
Conclusion
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Our study extends previous research by demonstrating that EP changes in MS may be present 
even in early MS and might be unmasked by a stressful environment. Our data suggest that EP 
deficits are not restricted to the processing of negative information but may affect the full range of 
emotional valence as well as the arousal dimension. Further, EP changes in early MS do not 
seem to be secondary to other MS-related neuropsychological or psychiatric symptoms. These 
observations might have implications for the clinical management of neuropsychological and 
affective symptoms in MS. The observation that the MRI environment may have a significant yet 
underestimated impact on behavioral outcome has potential methodological implications given 
the widespread use of MRI in patients with MS.
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Supporting Information
Additional Supporting Information may be found in the online version of this article:
Table S1: List of International Affective Picture System (IAPS) pictures used in the present study.
Table S2: Mean normative valence and arousal values for the different picture categories used in 
the present study.
 
Table S3: Descriptive Statistics: Valence and arousal ratings, recognition error rates and 
response times.
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Table 1. Demographic and clinical characteristics.
Descriptive statistics
Patients HC
Inference statistics
(whole 2x2 design)
PC MRI PC MRI p-value
N a 13 16 13 16 .998A
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Female/Male a 7/6 8/8 7/6 8/8 .999
Age (years) b 31.92 (7.32) 32.63 (9.13) 33.23 (7.12) 28.44 (7.95) .356
Education (years) b 17.53 (3.90) 15.57 (7.44) 17.58 (3.35) 17.78 (2.04) .545
Disease duration (month) c 32.69 (21.72) 29.19 (20.81) N.A. N.A. .663
Disability (EDSS [17]) c 1.15 (0.94) 1.18 (0.89) N.A. N.A. .923
Fatigue (MFIS) b 14.23 (16.90) 13.31 (12.97) 11.25 (9.56) 11.93 (9.48) .930
Depression (HADS) b 1.08 (1.25) 1.75 (1.65) 1.54 (1.51) 1.63 (1.78) .699
Depression (BDI-2) b 4.31 (4.66) 4.38 (4.22) 2.54 (4.09) 3.25 (3.80) .605
Anxiety (HADS) b 3.62 (1.66) 3.81 (2.37) 4.62 (1.80) 4.38 (1.75) .497
Cognition (MMSE) b 29.23 (1.30) 29.93 (0.26) 29.54 (0.97) 29.69 (0.60) .183 
Cognition (BRB-N) b
SRT      - LTS
             - CLTR
             - DR
SPART - Learning
             - DR
SDMT
PASAT
WLG
58.77 (14.05)
54.92 (17.22)
11.00 (2.04)
26.77 (3.70)
9.54 (1.13)
62.85 (22.82)
54.15 (4.65)
32.31 (5.71)
63.50 (9.30)
60.50 (12.01)
11.25 (1.57)
25.81 (3.31)
8.69 (2.24)
66.38 (14.55)
52.19 (6.59)
29.63 (5.90)
61.92 (7.47)
55.92 (10.70)
11.54 (0.78)
25.62 (3.95)
8.42 (2.23)
65.85 (9.71)
51.38 (6.25)
28.54 (6.68)
57.69 (10.22)
54.00 (14.23)
10.87 (1.45)
25.00 (3.50)
9.19 (1.28)
59.13 (9.88)
48.44 (9.17)
29.13 (5.28)
.389
.558
.672
.627
.387
.515
.179
.373
Quality of Life (SF-36) b
PCS  - vitality
         - physical functioning
         - bodily pain
         - gen. health perc.
MCS - physical role func.
         - emotional role func.
         - social role func.
         - mental health
64.62 (13.30)
95.77 (7.60)
89.69 (20.77)
66.08 (15.47)
82.69 (34.44)
94.87 (18.49)
93.27 (13.12)
79.38 (8.46)
59.69 (18.30)
97.50 (3.61)
88.38 (19.42)
71.44 (12.98)
89.06 (20.35)
91.67 (22.77)
94.53 (7.86)
76.50 (10.82)
62.50 (13.23)
97.08 (3.34)
90.42 (17.91)
71.75 (22.52)
100.00 (0.00)
97.22 (9.62)
94.79 (8.36)
78.33 (7.71)
67.67 (10.68)
97.67 (5.30)
88.00 (19.13)
83.27 (13.02)
90.00 (22.76)
88.89 (20.57)
97.50 (7.01)
78.93 (11.16)
.475
.773
.987
.042*1
.321
.686
.663
.860
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Life satisfaction (SWLS) b 25.67 (3.23) 28.40 (4.00) 27.00 (5.37) 27.73 (2.99) .343
Affective state (PANAS) b
- positive
- negative
32.67 (7.10)
11.92 (2.81)
31.53 (5.00)
12.07 (3.17)
32.85 (6.84)
12.00 (2.61)
34.12 (7.57)
13.19 (3.56)
.760
.641
Descriptive statistics: means (standard deviations).  Inference statistics: a Chi-square test; b Group (Pat/HC) x experimental setting (PC/MRI) 
analysis of variance (statistics for whole corrected model);  c t-test for independent samples; 1significant ME group (p = .047); * significant at p < 
.05.
Abbreviations: See Supporting information.
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Table 2: Inference statistics. Results of 4-way repeated measures analyses of covariance (rmANCOVA) for between 
subject factors group (Pat/HC) and experimental setting (PC/MRI) and within subject factors picture valence 
(NEG/NEU/POS) und arousal (L/H). Covariates: age, sex and BDI-2. Listed are significant main effects and interactions 
and associated post-hoc tests.
rmANCOVA ES Post-hoc
Outcome variable Effect F(df) p 2 comparisons p
Arousal F(1,51) = 13.84 <.001 .213 H > L <.001
Valence F(1.39,70.96) = 22.83 <.001 .309 NEU > NEG
POS > NEU 
POS > NEG
<.001
<.001
<.001
Valence*Group F(1.39,70.96) =   3.62 .046 .066 NEG: HC > Pat
NEU: HC > Pat
.036
.019
Valence rating
Valence*Group*Exp. setting F(1.39,70.96) =   7.71 .003 .131 NEG(MRI): HC > Pat
POS (MRI): HC > Pat
.004
.038
Group F(1,51) =   5.98 .018 .105 HC > Pat .031
Group*Exp. Setting F(1,51) =   6.26 .016 .109 MRI: HC > Pat .004
Arousal F(1,51) =   5.10 .028 .091 H > L <.001
Valence F(1.87,95.63)=   4.38 .017 .079 NEG > NEU
POS > NEU 
NEG > POS
<.001
<.001
<.001
Arousal*Valence F(1.70,86.87)=   4.67 .016 .084 NEG: H > L
NEU: H > L
POS: H > L
<.001
<.001
<.001
Arousal rating
Arousal*Group*Exp. setting F(1,51) =   5.07 .029 .090 MRI: HC(L) > Pat(L)
MRI: HC(H) > Pat(H)
Pat: PC(H) > MRI(H)
.039
<.001
.026
Error rates
Familiar pictures No effectsA
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Unfamiliar pictures Arousal*Exp. setting F(1,51) =   4.10 .048 .074 No significant post-hoc effects.
Response times
Familiar pictures Exp. setting F(1,51) =   8.58 .005 .144 MRI > PC .004
Arousal*Exp. setting F(1,51) =   6.53 .014 .113 L: MRI > PC
H: MRI > PC
.028
<.001
Arousal*Group*Exp. setting F(1,51) =   4.15 .047 .075
L: Pat(MRI) > Pat(PC)
H: Pat(MRI) > Pat(PC)
.005
.006
Unfamiliar pictures No effects
Abbreviations: NEG - negative, NEU - neutral, POS - positive, L - low arousal, H - high arousal, ES - effect size, SD - standard 
deviation
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Table 3: Correlation analyses. Results of correlation analyses between valence and arousal ratings and fatigue 
(MFIS), affective state (PANAS), quality of life (SF36) and Satisfaction with life (SWLS). Ratings adjusted for age, 
sex, BDI-2 and experimental setting. 
  Association  Correlation 95%CI 
Questionnaire Subscale Cat(Aro) Group 
(22) (p 2-
tailed) lower upper 
Valence rating 
Fatigue 
(MFIS) 
Sum score NEG(L) Pat 
HC 
-.495 (.016) 
-.120 (.595) 
-.755 
-.536 
.053 
.307 
Affective state 
(PANAS) 
Positive affect POS(H) Pat 
HC 
.425 (.043) 
-.006 (.977) 
.119 
-.497 
.673 
.501 
Quality of life 
(SF36) 
Emotional role function NEU(H)✣ Pat 
HC 
-.447 (.028) 
.572 (.004) 
-.756 
.036 
-.047 
.826 
 NEU(L) Pat 
HC 
-.586 (.003) 
.029 (.897) 
-.818 
-.414 
-.266 
.626 
 POS(H) Pat 
HC 
-.023 (.916) 
.414 (.049) 
-.523 
-.123 
.910 
.686 
General health perception POS(L) Pat 
HC 
.513 (.010) 
.003 (.988) 
.051 
-.457 
.816 
.491 
Physical functioning NEG(L)✣ Pat 
HC 
.472 (.020) 
-.312 (.147) 
.146 
-.651 
.781 
.032 
Physical role function NEG(L) Pat 
HC 
.448 (.028) 
.248 (.253) 
-.037 
-.373 
.721 
.741 
Social role function NEG(L) Pat 
HC 
.593 (.002) 
.170 (.437)     
.253 
-.271 
.783 
.576 
Physical health NEG(L)✣ Pat 
HC 
.554 (.005) 
-.427 (.042) 
.213 
-.837 
.826 
-.024 
Life satisfaction 
(SWLS) 
Sum score POS(L) Pat 
HC 
.553 (.006) 
-.289 (.192) 
.143 
-.641 
.849 
.476 
 POS(H) Pat 
HC 
.627 (.001)✻ 
-.258 (.246) .   
.068 
-.638 
.872 
.505 
Arousal rating 
Fatigue 
(MFIS) 
No associations      
Affective state 
(PANAS) 
Positive affect NEU(H) Pat 
HC 
-.434 (.039) 
-.013 (.955) 
-.760 
-.546 
.074 
.417 
 POS(H) Pat 
HC 
-.020 (.929) 
.039 (.864) 
-.436 
-.527 
.440 
.639 
Negative affect POS(H) Pat 
HC 
-.441 (.035) 
-.022 (.924) 
-.713 
-.419 
-.139 
.409 
Quality of life 
(SF36) 
Vitality NEG(H) Pat 
HC 
-.047 (.826) 
-.565 (.005) 
-.538 
-.816 
.399 
-.241 
  
 
 
 
 
 
 
Abbreviations: Cat - Picture category; Aro - Arousal category; NEG - negative, NEU - neutral, POS - positive, L - low arousal, 
H - high arousal MFIS: Modified Fatigue Impact Scale; PANAS: Positive and Negative Affect Scale; SWLF: Satisfaction with 
Life Scale; SF36: Short Form (36 item) Health Survey; Statistics: estimation of 95% CI based on 9999 bootstrapping opera-
tions; ✻ significant at Bonferroni corrected threshold 0.05/number of tested associations (p < .0021),  ✣ significant group 
difference due to CI estimates. 
 
 
 
 
 
 Mental health (sum 
score) 
NEG(H) Pat 
HC 
.066 (.756) 
-.456 (.029) 
-.406 
-.779 
.564 
-.089 
Life satisfaction 
(SWLS) 
No associations      
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Figure 1: (A) Exemplary IAPS-stimuli. (B) 9-level Self Assessment Manikin (SAM) Likert-scales (B) for the 
rating of the emotion elicited by the picture regarding its valence and arousal.
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Figure 2: Valence and arousal ratings (N=58). Displayed are group and experimental setting specific rating 
scores adjusted for the influence of age, sex and depression severity (BDI-2 score). (A) Valence ratings 
pooled across high and low arousing stimuli. (B) Arousal ratings pooled across all valence categories. 
Abbreviations: NEG – negative; NEU – neutral; POS – positive, PC – PC-group, MRI – MRI-group.
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